FDA Investigator Jean Blackston Hill

Jean Blackston Hill has inspections in 1 countries as of 06 Oct 2023. Jean Blackston Hill has collaborated with a combinined 3107 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
10
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100000006
Country:
United States of America
Co-Investigator(s):
Alicia M Mozzachio, Amy L Singer, Amy M Cramer, Anastasia I Offordile, Andrace Lde Yampert, Andrea D Swingle, Anita R Michael, Audrey Thereset Uy, Bei Y He, Benjamin J Smith, Brian S Keefer, Brooke K Higgins, Brooke K Seeman, Byungja E Marciante, Byunja E Marciante, Charles I Ann, Charles L Zhou, Charles M Edwards, Chryste D Best, Colleen M Damon, Constantin Y Philopoulos, Corrine M Carter, Craig D Zagata, Daniel J Grabicki, David A Paterson, Dawn L Wydner, Debara R Reese, Debara Reese, Deborah B Nixon, Debra J Bennett, Denise L Burosh, Denise M Digiulio, Denise M Visco, Investigator, Dennis E Guilfoyle, PhD, Diane T Bargo, Diane T O'brien, Dina A Tallman, Donald C Obenhuber, PhD, Donald L Lech, Doreen P Gubbay, Douglas A Campbell, E Marciante, Edward D Mcdonald, Emest F Bizjak, Emily J Orban, Emmanuel J Ramos, Frederick Razzaghi, Gayle S Lawson, George Pyramides, Gerald B Seaborn, Jr, Gianine E Tompkins, Jaison J Eapen, James C Illuminati, James R Birkenstamm, Jean Blackstone Hill, Jean M Kelahan, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Joanne Heim, Joanne M Hajoway, Jose M Cayuela, Jose R Hernandez, Joseph A Piechocki, Joseph F Mcginnis, RPh, Joseph R Strelnik, Joy Rkozlowski Klena, Julianne C Mccullough, Jullianne C Mccullough, Justine Tomasso, Karen E D'orazio, Karen M Montgomery (KMM), Karyn M Campbell, Kenneth M Gordon, Kenneth Nieves, Kinh Q Mac, Kristen D Evans, Kristina J Donohue, Kristina L Conroy, Kristina Mjoyce Pittman, L'oreal F Walker, Larry K Austin, Lauren Iacono Connors, PhD, Lawrence Harmon, Jr, Leigh Anne Myers, Liatte Kreuger, PharmD, Lisa B Orr, Lisa M Bellows, Loretta Nemchik, Lori A Holmquist, Lori A Holquist, Lori S Lawless, Luella J Rossi, Luis A Dasta, Lynette P Salisbury, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Sands, Maria Estrella, Matthew M Henciak, Matthew R Noonan, Mayar M Mussa, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Melissa J Garcia, Mercy Oyugi, Merideth K Rose, Michael Gurbarg, Michael L Casner, Michael R Klapal, Michael Serrano, Michael Shanks, MS, Michael Skelly, Michele L Forster, PhD, Montgomery Montgomery, Karen M, Muna Algharibeh, Myra K Casey, Nailing Zhang, Nancy L Rolli, Neali H Lucas, Niketa Patel, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Peter R Lenahan, Qiao Y Bobo, Rafeeq A Habeeb, Raymond T Oji, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Richard J Muzeni, Robert B Shibuya, MD, Robert D Tollefsen, Robert G Ruff, Robert J Ham, Robert J Maffei, Robert M Barbosa, Rw Mccullough, Sam Pepe, Sandra A Boyd, Sharon K Thoma, PharmD, Stephanie T Durso, Stephen J Koniers, Susan F Laska, MS, Susan P Bruederle, Suyang Qin, Suzanne M Healy, Suzanne M Muchene, Tammy L Chavis, Temar Q Williams, Thomas E Friel, Thomas J Arista, Thuy T Nguyen, LCDR, Tiffani D Wilson, Tina M Pawlowski, Tyanna N Hadley, Vesna V Stanoyevitch, Vlada Matusovsky, Walter L Fava, Wanda Y Fields, Wanda Y Honeyblue, Wayne E Seifert, William D Tingley, Yangmin Ning, Yumi J Hiramine, Yvesna C Blaise, Yvonne C Mcknight

Jean Blackston Hill's Documents

Publish Date Document Type Title
December, 2003 FDA 483 Cordis Corporation - Form 483, 2003-12-04
August, 2003 FDA 483 Response Labcorp Early Development Laboratories, Inc. - Form 483R, 2003-08-19
August, 2002 FDA 483 Response Actavis Mid-Atlantic, LLC. - Form 483R, 2002-10-03
August, 2002 FDA 483 Actavis Mid-Atlantic, LLC. - Form 483, 2002-08-02
October, 2001 FDA 483 Response Scientech Laboratories, Inc. - Form 483R, 2001-11-29
August, 2003 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2003-08-06
May, 2003 EIR Eli Lilly and Company - EIR, 2003-05-29
October, 2001 FDA 483 Scientech Laboratories, Inc. - Form 483, 2001-10-31
May, 2003 FDA 483 Eli Lilly and Company - Form 483, 2003-05-29
December, 2003 FDA 483 Response Cordis Corporation - Form 483R, 2003-12-22
August, 2003 EIR Labcorp Early Development Laboratories, Inc. - EIR, 2003-08-06
July, 2001 FDA 483 Intertek USA, Inc. - Form 483, 2001-07-25
December, 2000 FDA 483 Frontida BioPharm, LLC - Form 483, 2000-12-08
July, 2000 FDA 483 IGI, Inc. - Form 483, 2000-07-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more